Pharmacokinetic Mismatch of Tuberculosis Drugs
- 1 March 2012
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (3) , 1666
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacokinetic Mismatch Does Not Lead to Emergence of Isoniazid- or Rifampin-Resistant Mycobacterium tuberculosis but to Better Antimicrobial Effect: a New Paradigm for Antituberculosis Drug SchedulingAntimicrobial Agents and Chemotherapy, 2011
- Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active TuberculosisClinical Infectious Diseases, 2009
- Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum SmearsAntimicrobial Agents and Chemotherapy, 2007
- Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and TuberculosisClinical Infectious Diseases, 2005
- Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and RifapentineAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Bactericidal and Sterilizing Activities of Antituberculosis Drugs during the First 14 DaysAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazidThe Lancet, 1999
- Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.1981